• Immuno-oncology therapies activate the immune system, making it able to recognize cancer cells and destroy them and are expected to become an important part of cancer therapy in years to come. However, the science of immuno-oncology is still evolving. Brazil is a country uniquely primed with both opportunities and strengths for clinical oncology research. Among its strengths, the country counts with growing access to information, an unfortunately high cancer burden, improving patient education, access to new drugs for research centers, regional networks and human resources.
  • In May, AHF partnered with Policy Wisdom to convene a Deliberative Dialogue Day in Sao Paulo Brazil and Bogota, Colombia to discuss the content of an evidence brief about Improving Cancer Care in Latin America (and specifically lung cancer in Colombia).
  • Despite the availability of safe, effective and relatively accessible vaccines, adult vaccination remains at a low level globally, including in Latin America, resulting in millions of adults every year suffering illness, hospitalization and even death from vaccine-preventable diseases.
  • AHF recently convened a consensus conference among expert infectologists and rheumatologists to develop recommendations on vaccination for adults with autoimmune inflammatory rheumatic diseases in Latin America. The resulting paper is currently under review for publication.
  • Following a consensus conference convened by AHF to develop treatment and care recommendations for multiple sclerosis in Central American and the Caribbean, the resulting paper, Esclerosis múltiple en América Central y el Caribe: Estado actual y recomendaciones clínicas was published this month in Revista Mexicana de Neurociencia. Click here for a link to the full article.
  • After almost a year of collaboration, in December AHF convened the final meeting of 2016 of the expert CAM Dengue group whose objectives included analyzing the epidemiology and burden of disease of the dengue virus infection in Central America and the Caribbean and establishing a foundation for a vaccine implementation strategy in the Region.
  • SC CONTRA A DENGUE is the name of the app developed by the winners of the AHF-sponsored Dengue Prizes Brazil 2015. This innovative tool helps citizens to communicate dengue outbreaks directly to  ministry of health officials by setting an alert in a map where  cases of dengue are occurring.  Furthermore, it allows citizens to enroll as volunteers for the clinical trials of the dengue vaccine. The app is available for Android, iOs and Windows.
  • The growth of the CDx sector has been significant in the past several years with much of the activity focused in the area of oncology.  AHF convened a panel of Brazilian experts on oncology and companion diagnostics to review existing barriers and develop practical recommendations concerning policy fixes for the use of companion diagnostics (CDx) and personalized medicines for oncology in Brazil. 
  • The Americas Health Foundation, in conjunction with the Latin American Society for Pediatric Infectious Diseases (SLIPE), recently convened a Varicella Vaccination Task Force to advice for more effective programs and policies aimed at increasing the rate of varicella vaccination in the region. The Task Force developed a position paper on varicella prevention including a series of recommendations for expanding varicella vaccination throughout Latin America.